ARCA biopharma (ABIO) Competitor Comparison
We are evaluating the key criteria listed to compare ARCA biopharma (ABIO) against its competitors in the Biotechnology industry.
Market Capitalization
320 / 368Gross Profits
0 / 278Total Revenue
0 / 300EBITDA
45 / 337Free Cashflow
64 / 352Quick Ratio
3 / 357Earnings per Share
315 / 359Dividend yield
0 / 6Total Cash
276 / 358Performance 3 years
124 / 368Performance 5 years
180 / 368Performance 10 years
320 / 368Linearity 3 years
45 / 368Linearity 5 years
124 / 368Linearity 10 years
300 / 367Total Rank
138 / 368Dividend Rank
356 / 368Valuation Rank
182 / 368Piotroski Rank
354 / 368Muliplier Rank
10 / 368Market Capitalization - ABIO ranking 320 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.